The Bio-artificial Pancreas to Treat Type 1 Diabetes: Perspectives from Healthcare Professionals in the Netherlands

Overview

Journal J Clin Transl Endocrinol

Specialty Endocrinology

Date 2024 Nov 6

PMID 39502713

Authors

Dide de Jongh

Eline Bunnik

Behiye Ozcan

Robert Zietse

Emma Massey

Affiliations

Soon will be listed here.

Abstract

Aims: Healthcare professionals are relevant stakeholders because of their gatekeeper role in the clinic. This study aims to explore their perspectives on the potential future clinical implementation of the bio-artificial pancreas (BAP) for people with type 1 diabetes, and suitable target groups.

Methods: Semi-structured interviews were conducted with 17 healthcare professionals, including endocrinologists, nurses, and pancreas transplant surgeons. Inclusion was stopped once data saturation was reached. The audiotaped interviews were transcribed verbatim. Qualitative content analysis using an inductive approach was conducted to develop themes within a coding framework.

Results: Three main themes emerged: (1) hoped-for benefits, which included improved clinical outcomes, enhanced sense of normality, reduced mental burden for patients and their significant others, greater societal participation, and lower costs; (2) concerns, which included safety and effectiveness, inequitable access, accurate information, control over self-management, and organizational challenges; and (3) allocating the BAP during initial implementation, which included prioritizing people who lack effective treatment options, people with mental health issues, and vulnerable people.

Conclusions: The results of this study are important for researchers and practitioners involved in the development of the BAP, so that they can align its design and the process of clinical implementation with healthcare professionals' perspectives.

References

Fallon C, Jones E, Oliver N, Reddy M, Avari P . The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes. Diabet Med. 2022; 39(10):e14906. PMC: 9544624. DOI: 10.1111/dme.14906. View

Meraya A, Alwhaibi M, Khobrani M, Makeen H, Alqahtani S, Banji D . Direct Medical Expenditures Associated with Eye Complications among Adults with Diabetes in the United States. J Diabetes Res. 2020; 2020:2864069. PMC: 7245693. DOI: 10.1155/2020/2864069. View

Hex N, MacDonald R, Pocock J, Uzdzinska B, Taylor M, Atkin M . Estimation of the direct health and indirect societal costs of diabetes in the UK using a cost of illness model. Diabet Med. 2024; 41(9):e15326. DOI: 10.1111/dme.15326. View

de Jongh D, Lapre S, Ozcan B, Zietse R, Bunnik E, Massey E . Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes. Transplant Direct. 2024; 10(10):e1711. PMC: 11427030. DOI: 10.1097/TXD.0000000000001711. View

Farrington C . Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review. Diabet Med. 2017; 35(4):436-449. DOI: 10.1111/dme.13567. View

Foster E, Bridges N, Feurer I, Eggerman T, Hunsicker L, Alejandro R . Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia. Diabetes Care. 2018; 41(5):1001-1008. PMC: 5911786. DOI: 10.2337/dc17-1779. View

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

Pauley M, Berget C, Messer L, Forlenza G . Barriers to Uptake of Insulin Technologies and Novel Solutions. Med Devices (Auckl). 2021; 14():339-354. PMC: 8594891. DOI: 10.2147/MDER.S312858. View

Tharavanij T, Betancourt A, Messinger S, Cure P, Leitao C, Baidal D . Improved long-term health-related quality of life after islet transplantation. Transplantation. 2008; 86(9):1161-7. PMC: 2741424. DOI: 10.1097/TP.0b013e31818a7f45. View

10.

Nielsen H, Ovesen L, Mortensen L, Lau C, Joensen L . Type 1 diabetes, quality of life, occupational status and education level - A comparative population-based study. Diabetes Res Clin Pract. 2016; 121:62-68. DOI: 10.1016/j.diabres.2016.08.021. View

11.

Glocker V, Bachmann S, Hess M, Szinnai G, Burckhardt M . Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring. Front Endocrinol (Lausanne). 2022; 13:958671. PMC: 9367634. DOI: 10.3389/fendo.2022.958671. View

12.

Scheiner G, Sobel R, Smith D, Pick A, Kruger D, King J . Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009; 35 Suppl 2:29S-41S. DOI: 10.1177/0145721709333493. View

13.

Iturralde E, Tanenbaum M, Hanes S, Suttiratana S, Ambrosino J, Ly T . Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. Diabetes Educ. 2017; 43(2):223-232. PMC: 7162535. DOI: 10.1177/0145721717697244. View

14.

Kimbell B, Rankin D, Ashcroft N, Varghese L, Allen J, Boughton C . What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial. Diabetes Technol Ther. 2020; 22(6):468-475. PMC: 7262645. DOI: 10.1089/dia.2019.0466. View

15.

Peters M, Huisman E, Schoonen M, Wolffenbuttel B . The current total economic burden of diabetes mellitus in the Netherlands. Neth J Med. 2017; 75(7):281-297. View

16.

Balfe M, Brugha R, Smith D, Sreenan S, Doyle F, Conroy R . Why do young adults with Type 1 diabetes find it difficult to manage diabetes in the workplace?. Health Place. 2014; 26:180-7. DOI: 10.1016/j.healthplace.2013.12.016. View

17.

Bronner M, Peeters M, Sattoe J, Van Staa A . The impact of type 1 diabetes on young adults' health-related quality of life. Health Qual Life Outcomes. 2020; 18(1):137. PMC: 7218580. DOI: 10.1186/s12955-020-01370-8. View

18.

Lawton J, Kimbell B, Rankin D, Ashcroft N, Varghese L, Allen J . Health professionals' views about who would benefit from using a closed-loop system: a qualitative study. Diabet Med. 2020; 37(6):1030-1037. DOI: 10.1111/dme.14252. View

19.

Tanenbaum M, Adams R, Hanes S, Barley R, Miller K, Mulvaney S . Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use. J Diabetes Sci Technol. 2017; 11(3):484-492. PMC: 5505431. DOI: 10.1177/1932296816688010. View

20.

Tanenbaum M, Hanes S, Miller K, Naranjo D, Bensen R, Hood K . Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets. Diabetes Care. 2016; 40(2):181-187. PMC: 5864141. DOI: 10.2337/dc16-1536. View